Kathmere Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Kathmere Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$218K	Buy
2024 Q2	–	Sell
2024 Q1	$241K	Buy
2023 Q4	$214K	Buy
2021 Q1	–	Sell
2020 Q4	$24K	Buy